Sensitivity to cisplatin induced apoptosis was also increased with loss of CLPTM1L expression by shRNA in H838 tumor cells (Figure 3B), measured by colorimetric Caspase 3/7 activity assay. The gene discussed is CASP3; the disease is neoplasm.